Study
(Year) |
Reference | Country | Study Design | Exposure |
Timing of
Exposure |
Outcome 1 | Timing of Outcome | Sample Size 2 | High Quality 3 |
Barbone et al. (2019) | [61] | Italy, Slovenia, Croatia, Greece | Prospective | Hair Whole blood Umbilical cord |
20 weeks—delivery 20 weeks—delivery At delivery |
Bayley-III | 18 months | 628–1086 | Yes |
Boucher et al. (2014) | [55] | Canada | Prospective | Umbilical cord | At delivery | FTII, A-not-B test, BSID-II | 6.5, 11 months | 94 | Yes |
Castriotta et al. (2020) | [62] | Italy | Prospective | Umbilical cord | 20–32 weeks gestation | Bayley-III cognitive | 40 months | 323 | No |
Daniels et al. (2004) | [74] | United Kingdom | Prospective | Umbilical cord | At delivery | MCDI, DDST | 15, 18 months | 1054 | Yes |
Davidson et al. (2008) | [50] | Republic of Seychelles | Prospective | Hair | At delivery | BSID-II | 9, 30 months | 225–228 | No |
Freire et al. (2018) | [68] | Spain | Prospective | Placenta | At delivery | MSCA | 48-60 months | 302 | No |
Golding et al. (2016) | [76] | United Kingdom | Prospective | Whole blood | 11 weeks gestation | Modified DDST | 6, 18, 30, 42 months | 2394–2721 | No |
Hu et al. (2016) | [73] | China | Prospective | Whole blood Umbilical cord |
At delivery | GDS | 12 months | 410 | Yes |
Jedrychowski et al. (2007) | [56] | Poland | Prospective | Umbilical cord | At delivery | BSID-II | 12, 24, 36 months | 270–374 | No |
Kim S et al. (2008) | [57] | South Korea | Prospective | Whole blood Umbilical cord |
At delivery | BSID-II, SMS | 13-24 months | 49–118 | No |
Kim Y et al. (2018) | [48] | South Korea | Prospective | Whole blood Whole blood Umbilical cord |
12–20 weeks gestation 28–42 weeks gestation At delivery |
BSID-II | 6, 12, 24, 36 months | 414–790 | Yes |
Lederman et al. (2008) | [58] | USA | Prospective | Umbilical cord | At delivery | BSID-II, WPPSI-R | 12, 24, 36, 48 months | 107-132 | No |
Lin et al. (2013) | Taiwan | Prospective | Umbilical cord | At delivery | CDIIT | 24 months | 230 | No | |
Llop et al. (2012) | [59] | Spain | Prospective | Umbilical cord | At delivery | BSID-II | 14 months | 1683 | Yes |
Marques et al. (2009) | [45] | Brazil | Prospective | Hair | At delivery | GDS | 6, 36, 60 months | 82 | No |
Nisevic et al. (2019) | [63] | Croatia, Italy | Prospective | Umbilical cord | At delivery | Bayley-III | 18 months | 257 | Yes |
Nyanza et al. (2020) | [46] | Tanzania | Prospective | Whole blood | 16–27 weeks gestation | MDAT | 6–12 months | 429 | No |
Oken et al. (2005) | [70] | USA | Prospective | Hair | At delivery | VRM | 6 months | 135 | No |
Oken et al. (2008) | [69] | USA | Prospective | Erythrocyte | 2nd trimester | PPVT, WRAVMA | 36 months | 341 | Yes |
Polanska et al. (2013) | [49] | Poland | Prospective | Hair | 30–34 weeks gestation | Bayley-III | 12–24 months | 303 | No |
Prpic et al. (2017) | [72] | Croatia | Prospective | Umbilical cord | At delivery | Bayley-III | 18 months | 135 | Yes |
Rothenberg et al. (2016) | [44] | China | Prospective | Whole blood Hair |
At delivery | BSID-II | 12 months | 270 | Yes |
Shah-Kulkarni et al. (2020) | [53] | South Korea | Prospective | Whole blood Whole blood Umbilical cord |
12–20 weeks gestation > 28 weeks gestation At delivery |
K-BSID-II | 6 months | 321-467 | No |
SnojTratnik et al. (2017) | [64] | Slovenia, Croatia | Prospective | Hair Umbilical cord |
34 weeks gestation/at delivery At delivery |
Bayley-III | 16–20 months | 280–357 | No |
Strain et al. (2015) | [54] | Republic of Seychelles | Prospective | Hair | At delivery | BSID-II, CDI | 20 months | 1241–1265 | No |
Suzuki et al. (2010) | [43] | Japan | Prospective | Hair | At delivery | NBAS | 3 days | 498 | Yes |
Tatsuta et al. (2014) | [67] | Japan | Prospective | Umbilical cord | At delivery | K-ABC | 42 months | 287 | No |
Tatsuta et al. (2017) | [71] | Japan | Prospective | Umbilical cord | At delivery | BSID-II, KSPD | 18 months | 566 | Yes |
Valent et al. (2013) | [65] | Italy | Prospective | Hair Umbilical cord |
20–22 weeks gestationAt delivery | Bayley-III | 18 months | 271–505 | Yes |
Wang et al. (2019) | [66] | China | Prospective | Umbilical cord | At delivery | NBNA Bayley-III |
3 days18 months | 172–265 | No |
Wu et al. (2014) | [75] | China | Prospective | Umbilical cord | At delivery | NBNA | 3 days | 418 | No |
Xu et al. (2016) | [47] | USA | Prospective | Whole blood Umbilical cord |
16 weeks—delivery At delivery |
NNNS | 5 weeks | 344 | Yes |
1 For explanation of abbreviations, see Table 2. 2 Size of primary analysis, or a range if there were multiple primary analyses. 3 12 or more quality assessment criteria met, including adjustment for key confounders.